Source: Eur Respir J, 54 (5) 1900847; 10.1183/13993003.00847-2019
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
Annelore Sacreas, Jean-Luc Taupin, Marie-Paule Emonds, Liesbeth Daniëls, Dirk E. Van Raemdonck, Robin Vos, Geert M. Verleden, Bart M. Vanaudenaerde, Antoine Roux, Stijn E. Verleden. Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction. Eur Respir J, 54 (5) 1900847; 10.1183/13993003.00847-2019

Member's Comments

No comment yet.

Related content which might interest you: Intragraft donor-specific antibodies and lung transplantation Source: Eur Respir J, 54 (5) 1901937; 10.1183/13993003.01937-2019 Year: 2019 Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation Source: Eur Respir J, 50 (5) 1701248; 10.1183/13993003.01248-2017 Year: 2017 Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome Source: Eur Respir J, 52 (2) 1701898; 10.1183/13993003.01898-2017 Year: 2018 Pre-transplant soluble CD30 is a stronger predictor of BOS than anti-HLA antibodies occurring after lung transplantation Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 The impact of pre-transplant donor specific anti-HLA antibodies (DSAs) on lung transplant outcome: A single center experience Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation Source: Annual Congress 2012 - Novel approaches to lung transplantation Year: 2012 T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients Source: Eur Respir J 2006; 28: Suppl. 50, 344s Year: 2006 A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome Source: Eur Respir J, 58 (5) 2004090; 10.1183/13993003.04090-2020 Year: 2021 Pathophysiology of the lung allograft: pathways of graft rejection Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005 Pronounced neutrophil-rich inflammation in induced sputum of lung transplant recipients with chronic rejection Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD) Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 TNFα-308 polymorphism associates with acute lung allograft rejection Source: Eur Respir J 2005; 26: Suppl. 49, 175s Year: 2005 Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 178s Year: 2004 Evidence of indirect allorecognition of HLA /non-HLA antigens expressed by bronchial epithelial cells from lung transplant recipients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Significance of anti-HLA immunization in lung transplantation Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations Year: 2011 Basiliximab induction reduces the incidence of acute rejection in lung transplant patients Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016